The InnoMedCatalyst project, an initiative funded by the European Union through the Interregional Innovation Investment Instrument (I3), marked a milestone by organizing the first edition of the InnoMedCatalyst Startup Demo Day, held on 14 November 2025 in Bologna.
The event successfully concluded an intensive 8-week program of mentoring, capacity building, and tailored support offered to health innovators from across Europe. More than 150 stakeholders, an international jury of reputable investors, and a growing network of over 40 mentors from 10 European countries and beyond confirmed the consortium’s commitment to supporting investment readiness and entrepreneurship development based on specialized expertise.
Thanks to the mentors from the Imago-Mol ecosystem
We are grateful to the mentors who participated on behalf of the Imago-Mol Cluster:
• Stefan Busnatu, Vice-Rector for Innovative Biotechnologies and Digitalization at the “Carol Davila” University of Medicine and Pharmacy Bucharest, and cardiologist at “Bagdasar-Arseni” Emergency Clinical Hospital;
• Ion-Gheorghe Petrovai, co-founder and director of FreshBlood HealthTech.
It was also an important opportunity to reconnect with the partner clusters of the InnoMedCatalyst project, members of the MEDIC NEST Meta-Cluster in Precision Medicine, currently coordinated by the Imago-Mol Cluster.
18 European startups, innovative solutions, and a vision for 5P Medicine
A total of 18 European startups and early-stage small enterprises presented innovative solutions aligned with the five pillars of the healthcare systems of the future:
personalised, predictive, preventive, participatory, and precision medicine (5P Digital Medicine) — strategic directions at the core of the InnoMedCatalyst project.
The startups come from 9 European regions: Romania, Bulgaria, Greece, Italy, Poland, Belgium, Spain, Portugal, and Madeira.
Participating startups from Romania
• MedRadar
• Integrated Data Solutions
• Eldie
• OncoPharmAi
InnoMedCatalyst Startup Demo Day 2025 Awards
After a full day of pitches and thematic sessions, the international jury announced the winners:
🏆 Best Startup of the Day:
AIGEA Medical (Italy)
Awards:
• 3 months of access to the Dennemeyer Octimine business intelligence tool
• Voucher for participation in the HealthTech Investor Summit, Utrecht, the Netherlands (8–10 December), an event organized by consortium partner BIOVIA.
Special Mentions:
• Best Pitch: Metablue Solutions (Portugal)
• Highest Potential: ablute (Portugal)
• Highest Innovation Potential in 5P Medicine: RareBioTech (Spain)
The InnoMedCatalyst consortium congratulates all participating startups and SMEs for their contributions and for their dedication to accelerating innovation in digital health across Europe.
The Investor E-Book, featuring all teams participating in the InnoMedCatalyst Accelerator, is available online.
What’s Next: Launch of the 2026 Acceleration Programme
InnoMedCatalyst announces the launch of the second edition of the Accelerator Programme in 2026.
More details will be published in December on the MEDIC-NEST and LSOS (Life Sciences Open Space Platform) websites, the official infrastructure used for the project’s Open Innovation Network Platform.
Upcoming Demo Days (2026)
-
June 2026, Piatra-Neamț (Romania) – hosted by Rubik Hub, under the umbrella of the North-East Regional Development Agency (project coordinator)
-
September 2026, Madeira (Portugal) – hosted by Startup Madeira
These events will strengthen interregional collaboration and will continue the project’s mission to build strong connections between innovators, mentors, and investors in high-precision MedTech.
About InnoMedCatalyst
InnoMedCatalyst is a project funded through the European I3 – Interregional Innovation Investments programme, aiming to strengthen the innovation capacity of European ecosystems in personalised medicine and precision medicine.
Through key activities such as:
-
Regional Value Chain Analysis
-
Peer Learning Programme
-
5P Digital Medicine Accelerator
-
Open Innovation Network Platform
-
Regional and interregional Roadmaps
-
Investment Project Portfolio
the project is laying the groundwork for investment-ready interregional projects by 2026.
The consortium consists of 13 partners representing 10 European regions:
North-East Romania, Małopolska, Emilia-Romagna, Flanders, Catalonia, Castilla y León, Attica, Sofia, Norte, and Madeira.
InnoMedCatalyst contributes to strengthening the MEDIC NEST Meta-Cluster and to developing a European White Paper in 5P Medicine, supporting the adoption and scaling of digital health solutions.
More information is available at:
👉 https://medicnest.eu/innomedcatalyst/
